Dr. Ali Tinazli

Angel investor in Irvine

Invests in AI

Dr. Ali Tinazli's investor profile lists AI alongside Healthcare & Biotech, MedTech & Medical Devices and Digital Health & HealthTech, at seed and early-stage venture. The record holds 1 deal, among them Migraine.AI.

Email Investor

Email Investor

Credits to line up before a seed round

Dr. Ali Tinazli backs companies at seed and early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Migraine.AI

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, MedTech & Medical Devices, Digital Health & HealthTech, Fintech
Rounds
Seed, Early-stage venture
Profile
Angel investor
Deals on record
1
Based in
Irvine, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Dr. Ali Tinazli invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Dr. Ali Tinazli's investor profile, together with Healthcare & Biotech, MedTech & Medical Devices and Digital Health & HealthTech. The stages on record are seed and early-stage venture.
Which companies has Dr. Ali Tinazli backed?
The record lists 1 deal, including Migraine.AI. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Dr. Ali Tinazli?
For a company raising a seed round, AI Perks lists credits such as Modal (up to $50,000), Ansys (up to $15,000), Redis (up to $10,000) and Microsoft Azure (up to $25,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor